{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:20:06Z","timestamp":1785284406472,"version":"3.55.0"},"update-to":[{"DOI":"10.1371\/journal.pntd.0007370","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T00:00:00Z","timestamp":1624233600000}}],"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013996","name":"Global Health Innovative Technology","doi-asserted-by":"crossref","award":["2013-212"],"award-info":[{"award-number":["2013-212"]}],"id":[{"id":"10.13039\/501100013996","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"\n Background<\/jats:title>\n Praziquantel (PZQ) is currently the only recommended drug for infection and disease caused by the schistosome species that infects humans; however, the current tablet formulation is not suitable for pre-school age children mainly due to its bitterness and the large tablet size. We assessed the palatability of two new orally disintegrating tablet (ODT) formulations of PZQ.<\/jats:p>\n <\/jats:sec>\n \n Methodology<\/jats:title>\n \n This randomized, single-blind, crossover, swill-and-spit palatability study (NCT02315352) was carried out at a single school in Tanzania in children aged 6\u201311 years old, with or without schistosomiasis infection as this was not part of the assessment. Children were stratified according to age group (6\u20138 years or 9\u201311 years) and gender, then randomized to receive each formulation in a pre-specified sequence. Over 2 days, the children assessed the palatability of Levo-Praziquantel (L-PZQ) ODT 150 mg and Racemate Praziquantel (Rac-PZQ) ODT 150 mg disintegrated in the mouth without water on the first day, and L-PZQ and Rac-PZQ dispersed in water and the currently available PZQ 600 mg formulation (PZQ-Cesol) crushed and dispersed in water on the second day. The palatability of each formulation was rated using a 100 mm visual analogue scale (VAS) incorporating a 5-point hedonic scale, immediately after spitting out the test product (VAS\n t = 0<\/jats:sub>\n primary outcome) and after 2\u20135 minutes (VAS\n t = 2\u20135<\/jats:sub>\n ).\n <\/jats:p>\n <\/jats:sec>\n \n Principal findings<\/jats:title>\n \n In total, 48 children took part in the assessment. Overall, there was no reported difference in the VAS\n t = 0<\/jats:sub>\n between the two ODT formulations (p = 0.106) without water. Higher VAS\n t = 0<\/jats:sub>\n and VAS\n t = 2\u20135<\/jats:sub>\n scores were reported for L-PZQ ODT compared with Rac-PZQ ODT in older children (p = 0.046 and p = 0.026, respectively). The VAS\n t = 0<\/jats:sub>\n and VAS\n t = 2\u20135<\/jats:sub>\n were higher for both ODT formulations compared with the standard formulation (p<0.001 for both time points). No serious adverse events were reported.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions\/Significance<\/jats:title>\n The new paediatric-friendly formulations dispersed in water were both found to be more palatable than the existing standard formulation of PZQ. There may be gender and age effects on the assessment of palatability. Further research is needed for assessing efficacy and tolerability of the newly ODTs Praziquantel drug in younger children.<\/jats:p>\n <\/jats:sec>\n \n Trial registration<\/jats:title>\n \n The trial was registered on ClinicalTrials.gov (\n NCT02315352<\/jats:ext-link>\n ) and in the Pan African Clinical Trials Registry (\n PACTR201412000959159<\/jats:ext-link>\n ).\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1371\/journal.pntd.0007370","type":"journal-article","created":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T14:21:36Z","timestamp":1623248496000},"page":"e0007370","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Comparative palatability of orally disintegrating tablets (ODTs) of Praziquantel (L-PZQ and Rac-PZQ) versus current PZQ tablet in African children: A randomized, single-blind, crossover study"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4923-9023","authenticated-orcid":true,"given":"Muhidin K.","family":"Mahende","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elly","family":"Kourany-Lefoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1234-7445","authenticated-orcid":true,"given":"Brooke","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deon","family":"Bezuidenhout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelmina","family":"Bagchus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdunoor M.","family":"Kabanywanyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,6,9]]},"reference":[{"issue":"5","key":"pntd.0007370.ref001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.02582-16","article-title":"Praziquantel for Schistosomiasis: Single- Drug Metabolism Revisited, Mode of Action, and Resistance","volume":"61","author":"N Vale","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"pntd.0007370.ref002","unstructured":"WHO. Working to overcome the global impact of neglected tropical diseases First WHO report on neglected tropical diseases [Internet]. WHO Library Cataloguing-in-Publication Data. Geneva; 2010. Available from: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/44440\/9789241564090_eng.pdf;jsessionid=10074536C9555789B89EB424F8B37843?sequence=1"},{"issue":"2","key":"pntd.0007370.ref003","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.bjid.2014.11.004","article-title":"Impact of human schistosomiasis in sub-Saharan Africa","volume":"19","author":"AF Adenowo","year":"2015","journal-title":"Brazilian J Infect Dis"},{"issue":"1","key":"pntd.0007370.ref004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-3305-5-274","article-title":"Epidemiology and control of human schistosomiasis in Tanzania.","volume":"5","author":"HD Mazigo","year":"2012","journal-title":"Parasites and Vectors"},{"issue":"7","key":"pntd.0007370.ref005","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.pt.2020.04.012","article-title":"Schistosomiasis Control: Leave No Age Group Behind","volume":"36","author":"CL Faust","year":"2020","journal-title":"Trends Parasitol"},{"issue":"6","key":"pntd.0007370.ref006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0006484","article-title":"Schistosomiasis in Africa: Improving strategies for long-term and sustainable morbidity control.","volume":"12","author":"MD French","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0007370.ref007","first-page":"6736","article-title":"Human schistosomiasis","author":"DG Colley","year":"2014","journal-title":"Human schistosomiasis"},{"issue":"1","key":"pntd.0007370.ref008","first-page":"1","article-title":"Schistosomiasis infection in pre-school aged children in Uganda: A qualitative descriptive study to identify routes of exposure","volume":"19","author":"SPS Kibira","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"9","key":"pntd.0007370.ref009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0004946","article-title":"Expanding Praziquantel (PZQ) Access beyond Mass Drug Administration Programs: Paving a Way Forward for a Pediatric PZQ Formulation for Schistosomiasis.","volume":"10","author":"AL Bustinduy","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0007370.ref010","first-page":"11","article-title":"Comparative Assessment of Health Benefits of Praziquantel Treatment of Urogenital Schistosomiasis in Preschool and Primary School-Aged Children","volume":"2016","author":"WM Wami","year":"2016","journal-title":"Biomed Res Int"},{"issue":"04","key":"pntd.0007370.ref011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2329-9088.1000135","article-title":"Bilharzia: Pathology, Diagnosis, Management and Control.","volume":"01","author":"D U Olveda","year":"2013","journal-title":"Trop Med Surg"},{"issue":"1","key":"pntd.0007370.ref012","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00415-011-6133-7","article-title":"Neuroschistosomiasis","volume":"259","author":"AG Ross","year":"2012","journal-title":"J Neurol"},{"issue":"1","key":"pntd.0007370.ref013","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/1742395307084407","article-title":"The unacknowledged impact of chronic schistosomiasis","volume":"4","author":"CH King","year":"2008","journal-title":"Chronic Illn"},{"issue":"4","key":"pntd.0007370.ref014","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1086\/678507","article-title":"Mocumbi, Nick H. Kim JM. Schistosomiasis associated pulmonary hypertension","volume":"4","author":"DG Papamatheakis","year":"2014","journal-title":"Pulm Circ"},{"issue":"1","key":"pntd.0007370.ref015","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1186\/s13104-017-2904-2","article-title":"Coinfection of intestinal schistosomiasis and malaria and association with haemoglobin levels and nutritional status in school children in Mara region, Northwestern Tanzania: a cross-sectional exploratory study","volume":"10","author":"SM Kinung\u2019hi","year":"2017","journal-title":"BMC Res Notes."},{"issue":"2","key":"pntd.0007370.ref016","doi-asserted-by":"crossref","first-page":"e0228770","DOI":"10.1371\/journal.pone.0228770","article-title":"Prevalence and correlates of intestinal schistosomiasis infection among school-aged children in North-Western Tanzania","volume":"15","author":"RH Mnkugwe","year":"2020","journal-title":"PLoS One."},{"issue":"1","key":"pntd.0007370.ref017","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4314\/mejs.v5i1.85339","article-title":"Infection prevalence of Schistosoma mansoni and associated risk factors among schoolchildren in suburbs of Mekelle city, Tigray, Northern Ethiopia","volume":"5","author":"A Assefa","year":"2013","journal-title":"Momona Ethiop J Sci"},{"key":"pntd.0007370.ref018","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1859737","article-title":"Intestinal Schistosomiasis among Primary Schoolchildren in Two On-Shore Communities in Rorya District, Northwestern Tanzania: Prevalence, Intensity of Infection and Associated Risk Factors","volume":"2016","author":"DZ Munisi","year":"2016","journal-title":"J Parasitol Res"},{"issue":"6","key":"pntd.0007370.ref019","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.4269\/ajtmh.15-0467","article-title":"Predictive value of school-aged children\u2019s schistosomiasis prevalence and egg intensity for other age groups in Western Kenya","volume":"93","author":"PNM Mwinzi","year":"2015","journal-title":"Am J Trop Med Hyg"},{"issue":"7","key":"pntd.0007370.ref020","doi-asserted-by":"crossref","DOI":"10.1016\/j.pt.2006.05.001","article-title":"The control of schistosomiasis and soil- transmitted helminths in East Africa","volume":"22","author":"NB Kabatereine","year":"2006","journal-title":"TRENDS Parasitol"},{"issue":"7","key":"pntd.0007370.ref021","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ijpara.2016.01.006","article-title":"Impact of two rounds of praziquantel mass drug administration on Schistosoma mansoni infection prevalence and intensity: a comparison between community wide treatment and school based treatment in western Kenya","volume":"46","author":"IO Onkanga","year":"2016","journal-title":"Int J Parasitol"},{"issue":"9","key":"pntd.0007370.ref022","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S2214-109X(18)30345-0","article-title":"Preventive chemotherapy coverage for neglected tropical diseases: does one metric fit all?","volume":"6","author":"Cromwell EANF","year":"2018","journal-title":"LANCE Glob Heal"},{"key":"pntd.0007370.ref023","unstructured":"WHO. Preventive chemotherapy in human helminthiasis Preventive chemotherapy in human helminthiasis. Geneva; 2006."},{"issue":"3","key":"pntd.0007370.ref024","doi-asserted-by":"crossref","first-page":"e1574","DOI":"10.1371\/journal.pntd.0001574","article-title":"Implementing Preventive Chemotherapy through an Integrated National Neglected Tropical Disease Control Program in Mali","volume":"6","author":"S Bamani","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0007370.ref025","unstructured":"MOHSW. THE UNITED REPUBLIC OF TANZANIA, NATIONAL MASTER PLAN FOR NEGLECTED TROPICAL DISEASES (NTDs) A HIGH LEVEL SENSITIZATION MEETING. Dar Es Salaam; 2013."},{"key":"pntd.0007370.ref026","unstructured":"MoHSW. Strategic Master Plan for the Neglected Tropical Diseases Control Program 2017\u20132022 Tan- zania Mainland. Ministry of Health and Social Welfare. Dar Es Salaam; 2017."},{"issue":"2","key":"pntd.0007370.ref027","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.actatropica.2012.04.013","article-title":"Time to set the agenda for schistosomiasis elimination","volume":"128","author":"D Rollinson","year":"2013","journal-title":"Acta Trop"},{"key":"pntd.0007370.ref028","first-page":"1","article-title":"Schistosoma, other helminth infections, and associated risk factors in preschool-aged children in urban","author":"K Said","year":"2017","journal-title":"Tanzania"},{"issue":"4","key":"pntd.0007370.ref029","first-page":"197","article-title":"Schistosomiasis in African infants and preschool children: let them now be treated!","volume":"29","author":"M Betson","year":"2013"},{"issue":"2","key":"pntd.0007370.ref030","first-page":"1","article-title":"Paediatric schistosomiasis: What we know and what we need to know","volume":"12","author":"DNM Osakunor","year":"2018","journal-title":"PLoS Negl Trop Dis."},{"issue":"10","key":"pntd.0007370.ref031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0006852","article-title":"Safety, efficacy and acceptability of praziquantel in the treatment of Schistosoma haematobium in pre-school children of Kwale County, Kenya.","volume":"12","author":"BW Kimani","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pntd.0007370.ref032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13104-019-4246-8","article-title":"Schistosoma mansoni infection among preschool age children attending Erer Health Center, Ethiopia and the response rate to praziquantel.","volume":"12","author":"M Kemal","year":"2019","journal-title":"BMC Res Notes"},{"key":"pntd.0007370.ref033","first-page":"1","volume-title":"Impact of Annual Praziquantel Treatment on Urogenital Schistosomiasis in a Seasonal Transmission Focus in Central Senegal","author":"B Senghor","year":"2016"},{"key":"pntd.0007370.ref034","unstructured":"Pediatric Praziquantel Consortium, A Phase II clinical trial in Ivory Coast [Internet]. 2018 [cited 2020 Jun 23]. Available from: https:\/\/www.pediatricpraziquantelconsortium.org\/news-events\/pediatric-praziquantel-consortium-successfully-completed-phase-ii-ivory-coast"},{"issue":"1","key":"pntd.0007370.ref035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1371\/journal.pntd.0000357","article-title":"Taste, a new incentive to switch to (R)-praziquantel in schistosomiasis treatment","volume":"3","author":"T Meyer","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0007370.ref036","first-page":"17","article-title":"Developing a comprehensive response for treatment of children under 6 years of age with schistosomiasis: research and development of a pediatric formulation of praziquantel.","author":"J Reinhard-rupp","year":"2017"},{"issue":"8","key":"pntd.0007370.ref037","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.clinthera.2013.06.007","article-title":"The Bad Taste of Medicines: Overview of Basic Research on Bitter Taste.","volume":"35","author":"Julie A. Alan C. Spector Mennella","year":"2013","journal-title":"Clin Ther."},{"key":"pntd.0007370.ref038","unstructured":"EMEA. COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) REFLECTION PAPER: FORMULATIONS OF CHOICE FOR THE PAEDIATRIC [Internet]. London; 2006. Available from: https:\/\/www.ema.europa.eu\/en\/formulations-choice-paediatric-population"},{"key":"pntd.0007370.ref039","first-page":"1","article-title":"Early clinical development of artemether- lumefantrine dispersible tablet: palatability of three flavours and bioavailability in healthy subjects","author":"S Abdulla","year":"2010"},{"key":"pntd.0007370.ref040","first-page":"9","article-title":"Hedonic scale method of measuring food preferences","author":"D.R. Peryam","year":"1957","journal-title":"Food Technol"},{"key":"pntd.0007370.ref041","article-title":"The Emoji Scale: A Facial Scale for the 21st Century.","author":"M Swaney-stueve","year":"2018","journal-title":"Food Qual Prefer"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0007370","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T00:00:00Z","timestamp":1624233600000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0007370","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T13:43:59Z","timestamp":1624283039000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0007370"}},"subtitle":[],"editor":[{"given":"Suzy J.","family":"Campbell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,6,9]]},"references-count":41,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0007370","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/605170","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,9]]}}}